Pharma Cos. Slam Opioid Negotiation Class At 6th Circ.

By Emily Field · April 10, 2020, 8:47 PM EDT

Pharmaceutical companies on Friday again urged the Sixth Circuit to erase a district judge's certification of the "negotiation class" intended to help resolve the multidistrict opioid litigation, saying that nothing in...

To view the full article, register now.

Try a seven day FREE Trial

Already a subscriber? Click here to login

Documents

Brief

Case Information

Case Title

In re: Nat'l Prescription Opiate Lit

Case Number

Court

Appellate - 6th Circuit

Nature of Suit

3360 P.I.: Other

Date Filed

November 08, 2019

Recent Articles By Emily

November 05, 2024
Target Inks Individual Deals Over 'Non-Drowsy' Flu Medicine
October 10, 2024
Animal Medication Co. Sued Over Dog Arthritis Treatment Risks
August 26, 2024
Rival Can't Avoid Drugmaker's False Ad Claim Over Pain Med
August 21, 2024
Spine Implant Caused Patient's TB, Suit Says
July 23, 2024
Meet The Lead Ozempic Lawyers
June 24, 2024
Ark. AG Sues Pharmacy Benefit Managers Over Opioids
May 03, 2024
6 States Strike $270M Opioid Deal With Amneal
April 17, 2024
FDA's Foot-Dragging On Menthol Ban Sparks Frustration
March 26, 2024
Opioid Public Nuisance Claims 'Unique,' Ohio High Court Told
March 25, 2024
What To Watch As Opioid Litigation Goes To Ohio High Court